Fifth Lane Capital »

Phoenix Biotech Acquisition Class A shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $0 77k 0.00

More positions owned by Fifth Lane Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Merck & Co (MRK)
First Solar Put Option (FSLR)
Walt Disney Company (DIS)
Spdr Ser Tr S&p Ins Etf (KIE)
Select Sector Spdr Tr Financial (XLF)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Select Sector Spdr Tr Indl (XLI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
R1 RCM (RCM)
Ansys Put Option (ANSS)
First Tr Exchange Traded Consumr Staple (FXG)
Seaworld Entertainment (PRKS)
Brookfield Renewable Partner Partnership Unit (BEP)

View all positions for Fifth Lane Capital

Top funds holding Phoenix Biotech Acquisition Class A

Arch Venture Corp
Arena Investors
Honkamp Krueger Financial Services
Fifth Lane Capital
Geode Capital Management
Jane Street
Two Sigma Investments
CI Private Wealth
Birchview Capital
Hrt Financial
FNY Investment Advisers
Pineridge Advisors
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Phoenix Biotech Acquisition Class A